The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Novo-Nordisk

  • NVO
  • NYSE
  • Consumer Products
  • Latest 44.15
  • Currency US$
  • Change 0.17
  • Percent Change 0.387 %
  • Volume 494,745
  • Thu Apr 17, 2014 04:02 PM EDT NYSE data delayed 15 minutes.
  • Open 43.98
  • Previous Close 44.15
  • High 44.18
  • Low 43.80
  • Bidx0 41.38
  • Askx0 44.90
  • 52-week High02/25 48.42
  • 52-week Low06/24 29.898
  • Beta 7.00
  • Market Cap 118,106.10M
  • EPS 1.73
  • P/E 25.52
  • Forward P/E 20.73
  • PEG 1.73
  • Annual Dividend 0.61
  • Yield 1.881

News

Financials & Calendars

Income Statement

  • Sales $15,101,390,000
  • Earnings $4,550,280,000
  • Return on Equity 62.63%

Cash Flow

  • Cash Flow --
  • Cash $1,872,360,000
  • Current Ratio 1.74

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $12,527,010,000
  • Liabilities $4,945,480,000
  • Liabilities-to-Equity Ratio 0.65

Price Ratios

  • Price to Sales 7.82
  • Price to Book 15.58
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jan 30 n/a May 1 $0.44
Surprises Feb 2 14.73% n/a n/a
Dividends Mar 21 $0.83 n/a n/a
Splits Jan 9 5:1 n/a n/a

12 months ended Apr 19, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.

Related Securities
Symbol Type Latest % Chg

Officers

  • Lars Rebien Sorensen Chief Executive Officer
  • Jesper Brandgaard Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

NOVO ALLE DK 2880
BAGSVAERD DENMARK, G7
00000

lbpj@novonordisk.com
www.novonordisk.com

Ideas & Discussion

Live Discussion of NVO on StockTwits